Pacific Biosciences of California, Inc. (PACB) NASDAQ

1.33

+0.02(+1.53%)

Updated at August 18 02:47PM

Currency In USD

Valuation

Market Cap502.31M
Enterprise Value1.12B
P/E Ratio-0.76
PEG Ratio-0.03
Price/Sales Ratio2.56
Price/Book Ratio6.49
Enterprise/Revenue6.69
Enterprise/EBITDA-9.31

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-3.37
Operating Margin-4.25

Management Effectiveness

Return On Assets-0.64
Return On Equity-1.89

Income Statement

Revenue154.01M
Revenue/Share0.52
Gross Profit37.28M
EBITDA-242.79M
Net Income-309.85M
Diluted EPS-1.07

Balance Sheet

Total Cash314.74M
Total Cash/Share1.05
Total Debt699.22M
Total Debt/Equity11.37
Current Ratio6.92
Book Value Per Share0.2

Price History

52-Week Change-16.88
52-Week High2.72
52-Week Low0.85
Moving Average 50 Days1.36
Moving Average 200 Days1.51

Statistics

Average Volume9.8M
Shares Outstanding300.37M
% Held by Institutions75.83

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A